Participants who were Aβ+ had greater rates of dementia and a higher prevalence of carrying the APOE ε4 allele; had lower MMSE scores; and had greater levels of plasma p‐tau217, p‐tau181, and GFAP. The gene discussed is GFAP; the disease is dementia.